Recombinant Citrobacter koseri N-acetyl-D-glucosamine kinase (nagK)

What is N-acetyl-D-glucosamine kinase (nagK) and what role does it play in Citrobacter koseri?

N-acetyl-D-glucosamine kinase (nagK) in C. koseri, like its homolog in E. coli, is responsible for phosphorylating N-acetyl-D-glucosamine (GlcNAc) to form N-acetyl-D-glucosamine-6-phosphate (GlcNAc-6-P). This enzyme plays a critical role in bacterial cell wall recycling and carbohydrate metabolism. GlcNAc is a major component of bacterial cell walls (murein) and the lipopolysaccharide of the outer membrane . During bacterial growth, over 60% of the side wall murein is degraded, and the resulting GlcNAc is recycled through phosphorylation by nagK . This recycling process is essential for efficient cell wall maintenance and utilization of available resources in C. koseri.

The phosphorylated GlcNAc-6-P can then enter various metabolic pathways, including:

• Re-synthesis of murein or lipopolysaccharide components

• Entry into glycolysis for energy production

• Use in amino sugar metabolism

How does C. koseri nagK compare structurally to nagK enzymes from other bacteria?

While specific structural data for C. koseri nagK is not extensively documented, inferences can be drawn from related organisms. As C. koseri belongs to the Enterobacteriaceae family along with E. coli, their nagK enzymes likely share significant structural similarities. Based on data from other kinases, C. koseri nagK probably adopts a dimeric quaternary structure similar to the N-acetyl-D-glucosamine kinase characterized in other organisms .

Comparative analysis suggests that bacterial nagK enzymes typically contain:

• An ATP-binding domain with conserved motifs for catalysis

• A substrate-binding pocket specific for N-acetyl-D-glucosamine

• Regulatory regions that may respond to cellular metabolites

Unlike the bifunctional N-acetylglutamate synthase/kinases (NAGS/K) found in some bacteria such as Maricaulis maris, C. koseri nagK is likely a dedicated kinase without additional enzymatic domains .

What expression systems are most effective for producing recombinant C. koseri nagK?

For successful expression of recombinant C. koseri nagK, several expression systems can be considered, with E. coli being the most commonly used for bacterial proteins. Based on established protocols for similar enzymes, the following approaches are recommended:

• E. coli BL21(DE3) system: This strain is deficient in lon and ompT proteases, reducing degradation of recombinant proteins. Induction with IPTG allows controlled expression of the target protein.

• Expression vectors: pET systems (particularly pET28a or pET22b) with an N-terminal or C-terminal His-tag facilitate purification. The His-tag can be removed post-purification using specific proteases like thrombin or TEV protease if the tag affects enzyme activity.

• Optimization strategies:

  • Lower induction temperatures (16-20°C) to enhance solubility

  • Co-expression with chaperones if misfolding occurs

  • Use of solubility-enhancing fusion partners (MBP, SUMO, etc.)

For expression optimization, a systematic approach testing multiple variables should be implemented:

What purification strategies yield the highest purity and activity for recombinant C. koseri nagK?

A multi-step purification approach is recommended for obtaining high-purity, active recombinant C. koseri nagK:

• Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged nagK. Elution is typically performed with an imidazole gradient (20-250 mM).

• Intermediate purification: Ion exchange chromatography based on the theoretical pI of the protein. Anion exchange (Q-Sepharose) is often suitable for proteins with pI < 7.

• Polishing step: Size exclusion chromatography (Superdex 75 or 200) to separate monomeric/dimeric forms from aggregates and to exchange into the final storage buffer.

• Critical buffer considerations:

  • Include 5-10% glycerol to stabilize the enzyme

  • Maintain pH between 7.0-8.0

  • Add 1-5 mM DTT or 2-mercaptoethanol to prevent oxidation of cysteine residues

  • Consider adding 1-2 mM MgCl₂ as the enzyme requires Mg²⁺ for activity

Purification effectiveness can be monitored using:

• SDS-PAGE for purity assessment

• Enzyme activity assays at each purification step

• Western blotting for specific detection

• Dynamic light scattering for oligomeric state assessment

How should researchers store purified recombinant C. koseri nagK to maintain optimal activity?

Proper storage of purified recombinant C. koseri nagK is crucial for maintaining enzymatic activity. Based on protocols for similar kinases, the following storage conditions are recommended:

• Short-term storage (1-2 weeks):

  • 4°C in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl₂, 1 mM DTT, and 10% glycerol

  • Add protease inhibitors to prevent degradation

• Long-term storage (months to years):

  • Flash-freeze small aliquots in liquid nitrogen

  • Store at -80°C in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl₂, 1 mM DTT, and 25% glycerol

  • Avoid repeated freeze-thaw cycles

• Stability monitoring:

  • Periodically test activity using standard assays

  • Monitor protein integrity using SDS-PAGE

The dimeric nature of nagK enzymes suggests that protein concentration may affect stability, with higher concentrations (>1 mg/mL) potentially promoting dimer formation and enhancing stability .

What are the most reliable methods for measuring C. koseri nagK enzymatic activity?

Several complementary approaches can be used to measure C. koseri nagK activity with varying degrees of sensitivity and throughput:

• Coupled enzymatic assays:

  • ATP consumption can be coupled to NADH oxidation through pyruvate kinase and lactate dehydrogenase

  • The decrease in NADH absorbance at 340 nm correlates with nagK activity

  • Reaction components: nagK, GlcNAc, ATP, MgCl₂, phosphoenolpyruvate, NADH, pyruvate kinase, and lactate dehydrogenase

• Direct detection of ADP formation:

  • ADP-Glo™ assay quantifies ADP produced in the reaction

  • Luminescence-based detection offers high sensitivity

• Radiometric assays:

  • Using [γ-³²P]ATP to monitor transfer of radioactive phosphate to GlcNAc

  • Separation of products by thin-layer chromatography or paper chromatography

• HPLC-based methods:

  • Direct quantification of GlcNAc-6-P formation

  • Requires suitable derivatization for detection

A typical protocol for the coupled enzymatic assay would include:

How can researchers determine the kinetic parameters of recombinant C. koseri nagK?

Determining accurate kinetic parameters for C. koseri nagK requires careful experimental design and data analysis:

• Michaelis-Menten kinetics determination:

  • Vary GlcNAc concentration (0.01-10× expected Km) while keeping ATP constant and saturating

  • Vary ATP concentration while keeping GlcNAc constant and saturating

  • Plot initial velocity vs. substrate concentration

  • Fit data to appropriate models (Michaelis-Menten or Hill equation if cooperative behavior is observed)

• Handling non-Michaelian kinetics:

  • Based on observations from similar enzymes, C. koseri nagK may exhibit non-Michaelian kinetics with respect to N-acetyl-D-glucosamine

  • In such cases, apply more complex models like the Hill equation or mixed inhibition models

• Critical parameters to determine:

  • Km for GlcNAc and ATP

  • kcat (turnover number)

  • kcat/Km (catalytic efficiency)

  • Hill coefficient (if cooperative behavior is observed)

• Inhibition studies:

  • Determine Ki for product inhibition by ADP

  • Evaluate substrate inhibition at high GlcNAc concentrations

  • Assess the inhibitory effects of structural analogs

Expected kinetic parameters based on homologous enzymes might include:

• Km for GlcNAc: 0.04-0.06 mM

• Km for ATP: 0.1-0.5 mM

• kcat: 10-50 s⁻¹

• Inhibition constant (Ki) for ADP: 0.1-0.5 mM

What techniques are most informative for structural characterization of C. koseri nagK?

To gain comprehensive structural insights into C. koseri nagK, multiple complementary techniques should be employed:

• X-ray crystallography:

  • Provides atomic-level resolution of protein structure

  • Can capture enzyme-substrate complexes by co-crystallization or soaking

  • Crystallization conditions to screen: PEG-based precipitants, pH range 6.0-8.0, various salts (ammonium sulfate, sodium malonate)

• Small-angle X-ray scattering (SAXS):

  • Provides information about shape, size, and oligomeric state in solution

  • Useful for analyzing conformational changes upon substrate binding

• Circular dichroism (CD) spectroscopy:

  • Assesses secondary structure composition

  • Monitors thermal stability and unfolding

• Differential scanning fluorimetry (DSF):

  • Measures thermal stability (Tm) under various conditions

  • Useful for buffer optimization and ligand binding studies

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

  • Maps protein dynamics and conformational changes

  • Identifies regions involved in substrate binding or allosteric regulation

• Nuclear magnetic resonance (NMR) spectroscopy:

  • For studying protein dynamics in solution

  • Particularly useful for mapping ligand-binding sites

Based on structural studies of related enzymes, researchers should pay special attention to:

• The ATP-binding pocket and catalytic residues

• The GlcNAc-binding site

• Interface regions involved in dimer formation

• Potential allosteric regulation sites

How does C. koseri nagK compare functionally to nagK enzymes from other bacterial species?

Functional comparison of C. koseri nagK with homologs from other bacterial species provides insights into evolutionary adaptations and mechanistic conservation:

• Comparison with E. coli nagK:

  • E. coli nagK has been well-characterized as the primary enzyme responsible for GlcNAc phosphorylation in cell wall recycling

  • A nagK deletion mutant in E. coli lacked phosphorylated GlcNAc in its cytoplasm, indicating nagK is the only GlcNAc kinase expressed in E. coli

  • C. koseri nagK likely plays a similar unique role in GlcNAc phosphorylation

• Substrate specificity comparison:

  • Rat liver and kidney nagK can phosphorylate multiple substrates (GlcNAc, N-acetyl-D-mannosamine, D-glucose) with different affinities

  • C. koseri nagK likely exhibits similar substrate preferences but may have evolved specificity differences based on metabolic needs

• Metabolic context variations:

  • In some bacterial species, alternative pathways for GlcNAc utilization exist when GlcNAc-6-P levels are low

  • These differences in metabolic network integration could affect the physiological role of nagK across species

What insights can be gained from studying the evolutionary relationships of nagK across different bacterial taxa?

Evolutionary analysis of nagK provides valuable insights into its functional conservation and specialization:

• Phylogenetic relationships:

  • As members of Enterobacteriaceae, C. koseri and E. coli nagK enzymes likely share high sequence homology

  • Comparison with more distant bacterial taxa can reveal conserved catalytic residues versus variable regulatory elements

• Domain architecture analysis:

  • Some bacteria possess bifunctional enzymes like the N-acetylglutamate synthase/kinases (NAGS/K) found in Maricaulis maris

  • These bifunctional enzymes contain both an amino acid kinase (AAK) domain and an N-acetyltransferase (NAT) domain

  • C. koseri nagK likely possesses only the kinase domain, reflecting its specialized role

• Regulatory differences:

  • The allosteric regulation of nagK may vary across bacterial species

  • In some enzymes, the angle of rotation between domains can regulate activity by closing the predicted binding site

  • Understanding these regulatory differences can provide insights into metabolic adaptation

• Structural conservation patterns:

  • Critical catalytic residues are likely conserved across diverse nagK enzymes

  • Variable regions may reflect differences in substrate specificity or regulatory mechanisms

How does C. koseri nagK integrate into different metabolic pathways compared to other bacterial species?

The integration of nagK into bacterial metabolic networks can vary significantly across species:

• Cell wall recycling pathways:

  • In E. coli, GlcNAc from degraded murein is efficiently recycled through nagK

  • C. koseri likely employs similar recycling mechanisms due to its close phylogenetic relationship with E. coli

• Alternative utilization pathways:

  • Some bacterial species possess alternative pathways for GlcNAc utilization

  • In E. coli, a specific mechanism repressed by GlcNAc-6-P allows GlcNAc reutilization without nagK involvement under certain conditions

  • The presence of such alternative pathways in C. koseri remains to be fully characterized

• Connection to central metabolism:

  • Phosphorylated GlcNAc-6-P can enter glycolysis after conversion to fructose-6-phosphate

  • This connection to central carbon metabolism highlights nagK's role in energy generation from recovered cell wall components

• Amino sugar metabolism network:

  • In Proteobacteria, various amino sugar utilization pathways have been characterized

  • These pathways often involve specific transporters, kinases, and deacetylases

  • The integration of nagK within the broader amino sugar metabolism network may differ between C. koseri and other bacterial species

How can recombinant C. koseri nagK be used to study antimicrobial resistance mechanisms?

Recombinant C. koseri nagK can serve as a valuable tool for investigating antimicrobial resistance mechanisms:

• Connection to cell wall integrity and antibiotic susceptibility:

  • C. koseri is emerging as an important nosocomial pathogen with increasing antimicrobial resistance

  • The cell wall recycling pathway, in which nagK participates, is intricately linked to cell wall integrity and potentially to β-lactam resistance

  • Altered nagK function could affect peptidoglycan turnover and indirectly influence susceptibility to cell wall-targeting antibiotics

• Role in biofilm formation:

  • Amino sugar metabolism has been linked to biofilm formation in some bacteria

  • Biofilms contribute significantly to antimicrobial resistance

  • Investigating how nagK activity affects biofilm-associated resistance could provide novel insights

• Potential as a drug target:

  • Inhibition of essential metabolic enzymes represents a strategy for antimicrobial development

  • Understanding the structure and function of C. koseri nagK could facilitate rational inhibitor design

  • Comparative studies with human homologs would be essential for developing selective inhibitors

• Experimental approaches:

  • Generate nagK knockouts in C. koseri and assess changes in antibiotic susceptibility

  • Screen for small molecule inhibitors of nagK and evaluate their potentiating effects on existing antibiotics

  • Examine nagK expression levels in multiresistant clinical isolates of C. koseri

What site-directed mutagenesis strategies can reveal the structure-function relationships in C. koseri nagK?

Strategic site-directed mutagenesis can elucidate critical structure-function relationships in C. koseri nagK:

• Catalytic site mutations:

  • Target predicted ATP-binding residues (likely conserved lysine and aspartate residues)

  • Modify predicted GlcNAc-binding residues

  • Alter metal-binding residues that coordinate Mg²⁺

• Substrate specificity determinants:

  • Create point mutations in the substrate-binding pocket to alter specificity between GlcNAc and N-acetyl-D-mannosamine

  • Analyze changes in kinetic parameters to identify residues critical for discrimination between similar substrates

• Oligomerization interface:

  • If C. koseri nagK functions as a dimer like some homologous enzymes, mutations at the dimerization interface can reveal the importance of quaternary structure for activity

  • Techniques like size exclusion chromatography and analytical ultracentrifugation can confirm changes in oligomeric state

• Allosteric regulation sites:

  • Based on insights from structures of related enzymes, mutate potential allosteric sites

  • Assess changes in kinetic behavior, particularly cooperative binding or inhibitor sensitivity

• Domain motion regulators:

  • In related enzymes, the angle of rotation between domains can regulate activity

  • Mutations that affect interdomain flexibility could reveal mechanisms of catalytic regulation

How can systems biology approaches incorporate C. koseri nagK to understand cellular metabolism?

Systems biology approaches can provide comprehensive insights into how C. koseri nagK functions within the broader cellular network:

What is the potential role of C. koseri nagK in pathogenesis and host interaction?

Understanding C. koseri nagK's role in pathogenesis could provide important insights for clinical microbiology:

• Cell wall modification and immune evasion:

  • NagK's involvement in cell wall component recycling may affect peptidoglycan structure

  • Changes in cell wall composition can influence recognition by host immune receptors

  • Altered cell surface properties could affect adhesion to host tissues

• Growth in host environments:

  • C. koseri has been associated with various clinical infections, including central nervous system infections in immunocompromised individuals

  • NagK may contribute to bacterial fitness in nutrient-limited host environments by efficiently recycling cell wall components

  • Utilization of host-derived amino sugars could provide a growth advantage during infection

• Biofilm formation and persistence:

  • Amino sugar metabolism has been linked to biofilm formation in some bacteria

  • C. koseri is emerging as an important nosocomial pathogen , and biofilms contribute to persistence in hospital environments

  • NagK activity could influence extracellular matrix composition in biofilms

• In vivo expression studies:

  • Analyzing nagK expression during infection using techniques like RNA-seq

  • Comparing expression patterns between commensal growth and pathogenic scenarios

  • Correlating nagK expression with virulence factor production

How does nagK activity correlate with antimicrobial resistance profiles in clinical C. koseri isolates?

The relationship between nagK activity and antimicrobial resistance in clinical isolates is an important area for investigation:

• Epidemiological correlations:

  • C. koseri isolates have shown increasing antimicrobial resistance, including extended-spectrum β-lactamase (ESBL) production in 61.64% of hospital isolates

  • NDM-1-producing C. koseri isolates have been identified, raising serious clinical concerns

  • Correlating nagK sequence variants or expression levels with resistance profiles could identify potential associations

• Cell wall recycling and β-lactam resistance:

  • Changes in peptidoglycan recycling efficiency could potentially affect susceptibility to cell wall-targeting antibiotics

  • Investigate whether nagK overexpression or knockdown affects minimum inhibitory concentrations (MICs) of β-lactams

• Metabolic adaptation during antibiotic exposure:

  • Study nagK expression changes in response to antibiotic treatment

  • Determine if metabolic shifts involving nagK represent adaptation strategies during antibiotic stress

• Potential for combination therapies:

  • If nagK activity is linked to certain resistance mechanisms, targeting this enzyme in combination with existing antibiotics could enhance efficacy

  • Screen for nagK inhibitors that synergize with clinical antibiotics against resistant C. koseri strains

How can research on C. koseri nagK inform novel therapeutic approaches?

Research on C. koseri nagK could lead to innovative therapeutic strategies:

• Target validation studies:

  • Determine the essentiality of nagK under different growth conditions

  • Assess whether chemical or genetic inhibition of nagK sensitizes resistant C. koseri to existing antibiotics

  • Evaluate potential off-target effects by comparing with human homologs

• Structure-based drug design:

  • Use high-resolution structural data to design specific inhibitors of C. koseri nagK

  • Focus on unique structural features not present in human homologs to enhance selectivity

  • Employ fragment-based approaches to identify starting points for inhibitor development

• Metabolic vulnerability exploitation:

  • Identify conditions where nagK becomes particularly important for bacterial survival

  • Design therapeutic approaches that create or exacerbate these conditions

  • Combine with other metabolic inhibitors for synergistic effects

• Anti-virulence approaches:

  • If nagK activity influences virulence factor production or biofilm formation, inhibitors could reduce pathogenicity without directly killing bacteria

  • This approach might reduce selective pressure for resistance development

• Diagnostic applications:

  • Develop detection methods for specific nagK variants associated with resistance or virulence

  • Create rapid diagnostic tools to identify problematic C. koseri strains in clinical settings